In resolving the inquiry, the FTC did not challenge the core efficacy of Evolv's products, including the use of artificial intelligence in its technology. Instead, the focus of the inquiry was related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback